The Sickle Cell Blood Drive with the American Red Cross runs 9 a.m. to 2 p.m. Saturday at Apostolic Church of Jesus Christ, 2420 SE Bellview Ave.

According to the Pew Research Center, overall, 18% of Black adults report poor health, and Black Americans have higher rates ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

In honor of Black History Month, we're covering five milestones in Black health history, from the good and great to the bad and ...

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...

Greater attendance at the ODU vs. Marshall University men's basketball game could help fund making a little boy's wish.

Sickle cell disease can take a toll on couples, but it's entirely possible to maintain a healthy relationship, says columnist.

Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...

In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine study has concluded that there could be a significant impact on cognitive ...

Discover Agios Pharmaceuticals' Q4 2024 earnings highlights, growth plans for Pyrukynd in thalassemia & sickle cell, and insights on safety, clinical ...

Cash, cash equivalents and marketable securities as of December 31, 2024, were $1.5 billion compared to $806.4 million as of December 31, 2023.

Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...